2GY fundamentals

PHC Holdings Corp. engages in the development, manufacture, and sale of healthcare devices and services. It operates through the following segments: Diabetes Management, Healthcare Solutions, and Diagnosis and Life Science. The Diabetes Management segment deals with the development, manufacture, and sale of in-vitro diagnostic equipment such as self-monitoring blood glucose system, Point of Care Testing products, and electric drug injectors. The Healthcare Solutions segment develops and sells medical IT products such as receipt computers and electronic medical records, and conducts clinical laboratory diagnosis business. The Diagnosis and Life Science segment includes the development, manufacture and sale of research and medical support equipment, and pathological diagnosis equipment. The company was founded on August 13, 2013 and is headquartered in Tokyo, Japan.